Freelance sports writer Marty James covers various people and topics with ties to the Napa Valley sports scene.

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Some of the best quotes from Severance set the tone for Lumon Industries' mysterious operations. Other quotes mark pivotal ...

Welcome to the fourth quarter 2024 Phillips 66 earnings conference call. My name is Emily, and I'll be your operator for today's call. [Operator instructions] Please note that this conference is being ...

MADISON, WISCONSIN / ACCESS Newswire / January 31, 2025 / Nordic Consulting has been recognized as a top-ranked firm in the ...

CNW/ - Global Atomic Corporation ("Global Atomic" or the "Company") (TSX: GLO) (OTCQX: GLATF) (FRANKFURT: G12) is pleased ...